Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Needling and open filtering bleb revision after XEN-45 implantation-a retrospective outcome comparison.

Tytuł:
Needling and open filtering bleb revision after XEN-45 implantation-a retrospective outcome comparison.
Autorzy:
Steiner S; Department of Ophthalmology and Optometry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Resch H; Department of Ophthalmology and Optometry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Kiss B; Department of Ophthalmology and Optometry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Buda D; Department of Ophthalmology and Optometry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Vass C; Department of Ophthalmology and Optometry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .
Źródło:
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2021 Sep; Vol. 259 (9), pp. 2761-2770. Date of Electronic Publication: 2021 May 11.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Berlin ; New York : Springer-Verlag, c1982-
MeSH Terms:
Glaucoma Drainage Implants*
Trabeculectomy*
Humans ; Intraocular Pressure ; Retrospective Studies ; Tonometry, Ocular ; Treatment Outcome
References:
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):765-771. (PMID: 29356886)
Ophthalmol Ther. 2020 Mar;9(1):149-157. (PMID: 32062789)
Int J Ophthalmol. 2016 Dec 18;9(12):1814-1819. (PMID: 28003985)
Br J Ophthalmol. 2016 May;100(5):594-600. (PMID: 26733487)
Br J Ophthalmol. 2012 May;96(5):645-9. (PMID: 22275344)
J Glaucoma. 2018 Oct;27(10):849-855. (PMID: 29979337)
J Glaucoma. 2019 Aug;28(8):676-684. (PMID: 31162174)
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):983-996. (PMID: 30758653)
Ophthalmology. 2013 Dec;120(12):2532-2539. (PMID: 24070811)
J Glaucoma. 2018 Oct;27(10):869-873. (PMID: 30095603)
J Glaucoma. 2019 Jan;28(1):75-79. (PMID: 30461555)
Br J Ophthalmol. 2020 Aug;104(8):1125-1130. (PMID: 31727624)
Eye (Lond). 2019 May;33(5):761-766. (PMID: 30552422)
Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):359-365. (PMID: 27815624)
Ophthalmology. 2020 Jan;127(1):52-61. (PMID: 31034856)
J Glaucoma. 2020 Jan;29(1):11-14. (PMID: 31702711)
PLoS One. 2017 Aug 29;12(8):e0183142. (PMID: 28850575)
Am J Ophthalmol. 2019 Dec;208:219-225. (PMID: 31377287)
Contributed Indexing:
Keywords: Bleb revision; Filtering surgery; Glaucoma surgery; MIGS; Needling; XEN
Entry Date(s):
Date Created: 20210512 Date Completed: 20230420 Latest Revision: 20230420
Update Code:
20240105
PubMed Central ID:
PMC8380566
DOI:
10.1007/s00417-021-05204-1
PMID:
33977318
Czasopismo naukowe
Purpose: To compare efficacy and safety of needling and open bleb revision after XEN-45 surgery.
Methods: This retrospective study represents real-life data of patients who underwent XEN-45 surgery between November 2014 and June 2018 in the Vienna General Hospital. The following groups were formed for data evaluation: (PSEA) primary surgery secondary intervention allowed (n = 268); (PS) primary surgery until secondary intervention (n = 268); (N) first needling until additional secondary intervention (n = 55); (BR) first bleb revision until additional secondary intervention (n = 105). Main outcome measures were pre- and postoperative intraocular pressure (IOP), number of glaucoma medication (GM), Kaplan-Meier success rates, and secondary intervention rates. Success was defined as postoperative IOP < 21 mmHg and < 18 mmHg together with ≥ 20% IOP reduction with medication allowed.
Results: IOP (and GM) was lowered from 23.5 ± 8.0 (GM 3.1 ± 1.0) to 14.9 ± 8.2 mmHg (1.2 ± 1.4) in group PSEA and 18.1 ± 8.2 mmHg (1.5 ± 1.4) in group PS, in group N from 23.2 ± 10.1 (1.5 ± 1.0) to 19.3 ± 8.5 mmHg (2.2 ± 1.3) and in group BR from 22.0 ± 8.0 mmHg (2.5 ± 1.1) to 15.5 ± 6.4 mmHg (1.3 ± 1.5) after a median follow-up of 16.0, 8.4, 4.8, and 7.3 months, respectively. Success rates at 1 year were significantly higher in group BR (50.7%) compared to PS (37.7%, p = 0.019) and N (24.3%; p = 0.015). An additional intervention was required less frequently in group BR (17.1%) compared to group PS (49.6%, p < 0.001) and group N (54.5%, p < 0.001).
Conclusion: Our data appear to indicate favorable outcomes for open XEN bleb revision in terms of Kaplan-Meier success rates and secondary intervention rate compared to the needling procedure.
(© 2021. The Author(s).)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies